
FDA approval doesn’t automatically translate into a successful drug launch. Citius Pharmaceuticals Chairman and CEO Leonard Mazur joins Stewart Gandolf to discuss the capital, commercialization infrastructure, relationships and patient-access planning behind launching a therapy for a rare cancer.






































